Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-03-19 @ 8:15 AM
Study NCT ID:
NCT02536469
Status:
COMPLETED
Last Update Posted:
2017-02-03
First Post:
2015-08-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
COR01CD101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |